| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Sloane B, Doust JWL |
Psychophysiological investigations in experimental psychoses: results ... |
J. Ment. Sci. |
1954 |
| Abramson HA, Jarvik ME, K... |
Lysergic acid diethylamide (LSD-25): I. Physiological and perceptual r... |
J. Psychol. |
1955 |
| de Salva S, Evans RA |
Reversal of the effects of central nervous system depressants on EST b... |
J. Pharmacol. & Expe... |
1958 |
| Eisner BG, Cohen S |
Psychotherapy with lysergic acid diethylamide |
J Nerv Ment Dis |
1958 |
| Bulle PH |
Neurohumors in psychoses |
Chemical concepts of... |
1958 |
| Cohen S, Eisner BG |
Use of Lysergic acid diethylamide in a psychotherapeutic setting |
Arch.Neurol.Psychiat... |
1959 |
| Weintraub W, Silverstein ... |
The effect of LSD on the associative processes |
J.Nerv.Ment.Dis. |
1959 |
| Elmadjian F |
Excretion and metabolism of epinephrine and norepinephrine in man. |
Molecules and Mental... |
1959 |
| Ziolko HU |
Psychotrope Drogenwirkung und psychische Ausgangslage (Neurose) |
Neuro-Psychopharmaco... |
1959 |
| Quétin AM |
La Psilocybine en psychiatrie clinique et expérimentale |
Doctoral Thesis |
1960 |
| Wijsenbeek H, Landau R |
A review on the use of lysergic acid diethylamide (LSD-25) in psychiat... |
Harefuah |
1960 |
| Jovanovic D, Kandic B, Kr... |
Neka nasa iskustva u lecenju dusevnih bolesnika dietilamidom lizergicn... |
Vojno-sanit.Pregl. |
1960 |
| Jovanovic D, Kandic B, Kr... |
O nekim aspektima primene LSD-25 u nasoj Klinickoj psihijatrijsdkoj pr... |
Vojnosanit. Pregl. |
1960 |
| Shirahashi K |
Electroencephalographic study of mental disturbances experimentally-in... |
Folia Psychiat. Neu... |
1960 |
| Ling TM, Buckman J |
The use of lysergic acid in individual psychotherapy |
Proc. roy. Soc. Med. |
1960 |
| Rosen I |
Hallucinogenic drugs. Specific problems. |
Lancet |
1961 |
| DJ Douche |
Les effets de la psilocybine dans un cas d'hysterie |
Semaine d. hop. |
1961 |
| Sercl M, Lovarik J, Jaros... |
Klinische Erfahrungen mit Psilocybin (CY 39 Sandoz) |
Psychiatria et Neuro... |
1961 |
| Cosi V, Martinelli C |
Esperienze cliniche con la psilocibina nelle sindromi depressive |
Rass Studi Psichiat |
1965 |
| Cohen S |
A classification of LSD complications |
Psychosomatics |
1966 |
| Pöldinger W |
Zur Pharmakotherapie depressiver und ängstlicher Verstimmungszustände |
Osterreichische Apot... |
1973 |
| Munch JC |
Phencyclidine: pharmacology and toxicology |
Bulletin on Narcotic... |
1974 |
| Everitt BJ, Fuxe K, Hokfe... |
Serotonin, Catecholamines and Sexual Receptivity of Female Rats, Pharm... |
J Pharmacol |
1975 |
| Loo H, Caroli F |
La Conduite Toxicomaniaque dens ses Rapports a la Conduite Suicidaire |
Ann.Med.-Psychol |
1975 |
| Bowers MB |
Psychoses Precipitated by Psychotomimetic Drugs: A Follow-up Study |
Arch.Gen.Psychiat. |
1977 |
| Natale M, Dahlberg CC, Ja... |
The Effects Of LSD-25 And Dextroamphetamine On The Use Of Defensive La... |
J. clin. Psychol. |
1979 |
| Editorial |
Tod-geweihte: LSD hilft sterben |
Selecta |
1980 |
| Francès H, Lecrubier Y, P... |
Evidence for the role of noradrenaline in some effects of quipazine |
Psychopharmacology (... |
1980 |
| Carter SM, Reveley MA, Sa... |
Decreased urinary output of conjugated tyramine is associated with lif... |
Psychiatry Res |
1980 |
| Weaver KEC |
Letters to the Editor: LSD and Schizophrenia |
Arch. Gen. Psychiatr... |
1984 |
| Warnecke G |
[Psychosomatic dysfunctions in the female climactericClinical effectiv... |
Fortschr Med |
1991 |
| Gamma A, Frei E, Lehmann ... |
Mood state and brain electric activity in ecstasy users |
Neuroreport |
1999 |
| Berman RM, Cappiello A, A... |
Antidepressant effects of ketamine in depressed patients |
Biol Psychiatry |
2000 |
| Gamma A, Buck A, Berthold... |
No difference in brain activation during cognitive performance between... |
J Clin Psychopharmac... |
2001 |
| MacInnes, N, Handley, SL ... |
Former chronic methylenedioxymethamphetamine (mdma or ecstasy) users r... |
J Psychopharmacology |
2001 |
| McGregor IS, Gurtman CG, ... |
Increased anxiety and "depressive" symptoms months after MDMA ("ecstas... |
Psychopharmacology (... |
2003 |
| De Win MM, Reneman L, Rei... |
Mood disorders and serotonin transporter density in ecstasy users-the ... |
Psychopharmacology (... |
2004 |
| London ED, Simon SL, Berm... |
Mood disturbances and regional cerebral metabolic abnormalities in rec... |
Arch Gen Psychiatry |
2004 |
| Khorana N, Pullagurla MR,... |
Pharmacological and neurochemical evidence for antidepressant-likeeffe... |
Pharmacology, Bioche... |
2004 |
| Sumnall HR, Cole JC |
Self-reported depressive symptomatology in community samples of polysu... |
J Psychopharmacol |
2005 |
| Ranjan S, Chandra PS |
Modafinil-induced irritability and aggression?: a report of 2 bipolar ... |
J Clin Psychopharmac... |
2005 |
| Hayase T, Yamamoto Y, Yam... |
Behavioral effects of ketamine and toxic interactions with psychostimu... |
BMC Neurosci |
2006 |
| Furey ML, Drevets WC |
Antidepressant efficacy of the antimuscarinic drug scopolamine: a rand... |
Arch Gen Psychiatry |
2006 |
| Braida D, Limonta V, Pego... |
Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa... |
Psychopharmacology (... |
2007 |
| Linde K, Berner MM, Krist... |
St John's wort for major depression |
Cochrane Database of... |
2008 |
| Moussaieff A, Rimmerman N... |
Incensole acetate, an incense component, elicits psychoactivity by act... |
FASEB J |
2008 |
| Chartoff EH, Potter D, Da... |
Exposure to the Selective kappa-Opioid Receptor Agonist Salvinorin A M... |
Neuropsychopharmacol... |
2008 |
| Rogers G, Elston J, Garsi... |
The harmful health effects of recreational ecstasy: a systematic revie... |
Health Technol Asses... |
2009 |
| Kuchkarov UI, Ashurov ZSh... |
[Efficiency of noophen in heroin addiction] |
Lik Sprava |
2009 |
| Akinboro A, Mohamed KB, A... |
Antioxidants in aqueous extract of Myristica fragrans (Houtt.) suppres... |
J Zhejiang Univ-Sci ... |
2011 |
| Bell HJ, Azubike E, Haouz... |
The other respiratory effect of opioids: suppression of spontaneous au... |
J Appl Physiol (1985... |
2011 |
| Degenhardt L, Coffey C, R... |
The persistence of the association between adolescent cannabis use and... |
Addiction |
2012 |
| Niciu MJ, Grunschel BD, C... |
Two cases of delayed-onset suicidal ideation, dysphoria and anxiety af... |
J Psychopharmacol |
2013 |
| Zanos P, Georgiou P, Wrig... |
The Oxytocin Analogue Carbetocin Prevents Emotional Impairment and Str... |
Neuropsychopharmacol... |
2013 |
| Ellis JS, Zarate CA, Luck... |
Antidepressant treatment history as a predictor of response to scopola... |
Journal of Affective... |
2014 |
| Lally N, Nugent AC, Lucke... |
Anti-anhedonic effect of ketamine and its neural correlates in treatme... |
Transl Psychiatry |
2014 |
| Nagele P, Duma A, Kopec M... |
Nitrous Oxide for Treatment-Resistant Major Depression: a Proof-of-Con... |
Biological Psychiatr... |
2014 |
| Zorumski CF, Nagele P, Me... |
Treatment-Resistant Major Depression: Rationale for NMDA Receptors as ... |
Front Psychiatry |
2015 |
| Henderson TA |
Practical application of the neuroregenerative properties of ketamine:... |
Neural Regen Res |
2016 |
| Gao M, Rejaei D, Liu H |
Ketamine use in current clinical practice |
Acta Pharmacol Sin |
2016 |
| Grunebaum MF, Galfalvy HC... |
Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression:... |
Am J Psychiatry |
2017 |
| Morley S, Slaughter J, Sm... |
Death from Ingestion of E-Liquid |
Journal of Emergency... |
2017 |
| Geiger HA, Wurst MG, Dani... |
DARK Classics in Chemical Neuroscience: Psilocybin |
ACS Chem Neurosci |
2018 |
| Zhang K, Hashimoto K |
Lack of Opioid System in the Antidepressant Actions of Ketamine |
Biol Psychiatry |
2019 |
| Cozzi NV, Daley PF |
Synthesis and characterization of high-purity N,N-dimethyltryptamine h... |
Drug Test Anal |
2020 |
| Nicholas B.GiancolaBAClay... |
A “trip” to the ICU: intravenous injection of psilocybin |
Journal of the Acade... |
2021 |
| Bennett R, Yavorsky C, Br... |
Ketamine for Bipolar Depression: Biochemical, Psychotherapeutic, and P... |
Front Psychiatry |
2022 |
